Recovery: A Prospective Multicenter Study of Different Surgical Methods in the Treatment of High Myopic Macular Schisis

Sponsor
Aier School of Ophthalmology, Central South University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04146350
Collaborator
(none)
400
1
8
32
12.5

Study Details

Study Description

Brief Summary

In view of the current problem of treating high myopic macular schisis, the main purpose of our study is to find out the most appropriate time of surgical intervention, to compare the effectiveness and safety of various surgical methods in the treatment of high myopic macular schisis, and to find out the advantages and disadvantages of each surgical method in the treatment of MF. As well as the outcomes and complications of long-term follow-up.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PPV+/-Cat
  • Procedure: PPV+/-Cat+Gas
  • Procedure: PPV+ILM+/-Cat+/-Gas
  • Procedure: PPV+ILM+/-Cat+/-Oil
  • Procedure: PSR
  • Procedure: PSR+ PPV+ILM+/-Cat+/-Oil (or Gas)
  • Procedure: Gas
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Multicenter Study of Different Surgical Methods for the Treatment of Macular Schisis in High Myopia Based on the Real World
Actual Study Start Date :
Oct 7, 2019
Anticipated Primary Completion Date :
Oct 7, 2021
Anticipated Study Completion Date :
Jun 7, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Active Comparator: PPV+/-Cat

Procedure: PPV+/-Cat
pars plana vitrectomy+/-cataract

Active Comparator: PPV+/-Cat+Gas

Procedure: PPV+/-Cat+Gas
pars plana vitrectomy+/-cataract+gas tamponade

Active Comparator: PPV+ILM+/-Cat+/-Gas

Procedure: PPV+ILM+/-Cat+/-Gas
pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-gas tamponade

Active Comparator: PPV+ILM+/-Cat+/-Oil

Procedure: PPV+ILM+/-Cat+/-Oil
pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-silicone oil tamponade

Active Comparator: PSR

Procedure: PSR
posterior scleral reinforcement

Active Comparator: PSR+ PPV+ILM+/-Cat+/-Oil (or Gas)

Procedure: PSR+ PPV+ILM+/-Cat+/-Oil (or Gas)
posterior scleral reinforcement+pars plana vitrectomy+internal limiting membrane peeling+/-cataract+/-silicone oil tamponade (or gas)

Active Comparator: Gas

Procedure: Gas
gas tamponade alone

Outcome Measures

Primary Outcome Measures

  1. foveal thickness [change from baseline foveal thickness at 3, 6, 9, 12 months]

    measured by OCT

  2. retinal thickness of the most significant schisis [change from baseline at 3, 6, 9, 12 months]

    measured by OCT

Secondary Outcome Measures

  1. best corrected visual acuity [change from baseline at 3, 6, 9, 12 months]

    BCVA

  2. mf-ERG [change from baseline at 3, 6, 9, 12 months]

    multifocal-ERG

  3. Visual quality questionnaire [change from baseline at 3, 6, 9, 12 months]

    Visual quality questionnaire

  4. axial length [change from baseline at 3, 6, 9, 12 months]

    axial length measured by IOL Master

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. diopter ≤-6.00D or axial length ≥ 26.00mm;

  2. OCT showed macular schisis with or without macular retinal detachment;

  3. agreed to participate in this project and signed informed consent form.

Exclusion Criteria:
  1. OCT confirmed full-thickness macular hole with or without macular retinal detachment;

  2. submacular active or inactive CNV;

  3. previous vitreoretinal surgery and anti-glaucoma surgery;

  4. with rhegmatogenous retinal detachment, ocular trauma, glaucoma, corneal opacity and other ophthalmic diseases;

  5. complicated with severe systemic disease can not tolerate surgery or follow-up;

  6. do not agree to participate the project or disagree with the follow-up.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai Aier Eye Hospital Shanghai Shanghai China 200000

Sponsors and Collaborators

  • Aier School of Ophthalmology, Central South University

Investigators

  • Study Chair: Weisheng Li, Shanghai Aier Eye Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Aier School of Ophthalmology, Central South University
ClinicalTrials.gov Identifier:
NCT04146350
Other Study ID Numbers:
  • AM1901D3
First Posted:
Oct 31, 2019
Last Update Posted:
Oct 31, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 31, 2019